Microsoft and Meta CEOs defended their significant investments in AI amidst claims by Chinese startup DeepSeek of achieving similar performance at muc ...
AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...
Meta Platforms Inc. Chief Executive Officer Mark Zuckerberg exuded confidence in his company’s artificial intelligence strategy, saying 2025 will be a “really big year” in which its AI assistant will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback